
Layla D. Berry
Examiner (ID: 16889, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1609, 1623, 1693 |
| Total Applications | 1713 |
| Issued Applications | 1092 |
| Pending Applications | 106 |
| Abandoned Applications | 561 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14624547
[patent_doc_number] => 20190225641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Crystal Forms of Beta-Nicotinamide Mononucleotide
[patent_app_type] => utility
[patent_app_number] => 16/368052
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/368052 | Crystal forms of beta-nicotinamide mononucleotide | Mar 27, 2019 | Issued |
Array
(
[id] => 16598128
[patent_doc_number] => 20210024659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => NOVEL REACTIVE ALGINIC ACID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/041036
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041036
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041036 | Reactive alginic acid derivatives | Mar 26, 2019 | Issued |
Array
(
[id] => 17769366
[patent_doc_number] => 11401293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Oligosaccharide c-glycoside derivatives
[patent_app_type] => utility
[patent_app_number] => 17/040346
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12592
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040346
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040346 | Oligosaccharide c-glycoside derivatives | Mar 21, 2019 | Issued |
Array
(
[id] => 14893811
[patent_doc_number] => 20190290671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => HYPOLIPIDEMIC EFFECTS OF COMPOSITIONS COMPRISING BETA-GLUCOGALLIN
[patent_app_type] => utility
[patent_app_number] => 16/361457
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361457 | HYPOLIPIDEMIC EFFECTS OF COMPOSITIONS COMPRISING BETA-GLUCOGALLIN | Mar 21, 2019 | Abandoned |
Array
(
[id] => 18666311
[patent_doc_number] => 11773189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Pectin characterized by a low degree of methyl esterification and a high intrinsic viscosity
[patent_app_type] => utility
[patent_app_number] => 16/971572
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7893
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971572 | Pectin characterized by a low degree of methyl esterification and a high intrinsic viscosity | Mar 17, 2019 | Issued |
Array
(
[id] => 15493125
[patent_doc_number] => 20200046751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/353737
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353737
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353737 | Compounds and methods for treating neurological and cardiovascular conditions | Mar 13, 2019 | Issued |
Array
(
[id] => 14566877
[patent_doc_number] => 20190211045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/353824
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353824 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Mar 13, 2019 | Abandoned |
Array
(
[id] => 16628826
[patent_doc_number] => 20210047479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => HYDROGEL COMPOSITES COMPRISING CHITOSAN AND CELLULOSE NANOFIBERS
[patent_app_type] => utility
[patent_app_number] => 16/980383
[patent_app_country] => US
[patent_app_date] => 2019-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980383 | HYDROGEL COMPOSITES COMPRISING CHITOSAN AND CELLULOSE NANOFIBERS | Mar 12, 2019 | Abandoned |
Array
(
[id] => 14531613
[patent_doc_number] => 20190201427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => COMPOSITIONS CONTAINING TANNIC ACIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/298804
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298804 | COMPOSITIONS CONTAINING TANNIC ACIDS AND USES THEREOF | Mar 10, 2019 | Abandoned |
Array
(
[id] => 18233196
[patent_doc_number] => 11597745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => b-modified phosphoric acid compound precursor, b-modified phosphoric acid compound, reaction inhibitor and medicine containing the same, and method for inhibiting reaction
[patent_app_type] => utility
[patent_app_number] => 16/977525
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13811
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977525
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977525 | b-modified phosphoric acid compound precursor, b-modified phosphoric acid compound, reaction inhibitor and medicine containing the same, and method for inhibiting reaction | Mar 7, 2019 | Issued |
Array
(
[id] => 17497580
[patent_doc_number] => 11286273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Rhamnolipid compounds and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/257255
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5103
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257255 | Rhamnolipid compounds and use thereof | Mar 7, 2019 | Issued |
Array
(
[id] => 16695464
[patent_doc_number] => 10946033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment
[patent_app_type] => utility
[patent_app_number] => 16/293423
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34767
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293423 | 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment | Mar 4, 2019 | Issued |
Array
(
[id] => 15432367
[patent_doc_number] => 20200030366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => INULIN FOR PREVENTING ANTIBIOTIC RESISTANT INFECTION AND PATHOGEN COLONIZATION
[patent_app_type] => utility
[patent_app_number] => 16/287716
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16287716
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/287716 | Inulin for preventing antibiotic resistant infection and pathogen colonization | Feb 26, 2019 | Issued |
Array
(
[id] => 17938450
[patent_doc_number] => 11472891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Photocrosslinkable alginic acid derivative
[patent_app_type] => utility
[patent_app_number] => 16/976027
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 72675
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 391
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976027 | Photocrosslinkable alginic acid derivative | Feb 26, 2019 | Issued |
Array
(
[id] => 14833303
[patent_doc_number] => 20190275052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND A NUCLEOS(T)IDE ANALOGUE
[patent_app_type] => utility
[patent_app_number] => 16/282481
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282481 | COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND A NUCLEOS(T)IDE ANALOGUE | Feb 21, 2019 | Abandoned |
Array
(
[id] => 16512998
[patent_doc_number] => 20200392256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => STARCH WITH HIGH DIETARY FIBER CONTENT SUITABLY USABLE IN FOODS AND BEVERAGES
[patent_app_type] => utility
[patent_app_number] => 16/971576
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971576 | STARCH WITH HIGH DIETARY FIBER CONTENT SUITABLY USABLE IN FOODS AND BEVERAGES | Feb 21, 2019 | Abandoned |
Array
(
[id] => 16824228
[patent_doc_number] => 20210139521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => DIARYL TREHALOSE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/968075
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968075
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968075 | Diaryl trehalose compounds and uses thereof | Feb 20, 2019 | Issued |
Array
(
[id] => 16383180
[patent_doc_number] => 10808002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Method for preparing D-psicose crystal
[patent_app_type] => utility
[patent_app_number] => 16/279860
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4558
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279860 | Method for preparing D-psicose crystal | Feb 18, 2019 | Issued |
Array
(
[id] => 14497775
[patent_doc_number] => 20190192542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/277741
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16277741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/277741 | Nicotinoyl riboside compositions and methods of use | Feb 14, 2019 | Issued |
Array
(
[id] => 16525322
[patent_doc_number] => 20200399402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => CELLULOSE RESIN, MOLDING MATERIAL, MOLDED BODY, AND METHOD FOR PRODUCING CELLULOSE RESIN
[patent_app_type] => utility
[patent_app_number] => 16/976814
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976814 | Cellulose resin, molding material, molded body, and method for producing cellulose resin | Feb 13, 2019 | Issued |